Humacyte (HUMA) EBIT Margin Growth (5y) (2025)
Powered by 
Analysis
Humacyte (HUMA) EBIT Margin Growth (5y) (2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Krystal Biotech | 10.21 Bn | 9.36 Bn | 112.79 Mn |
| 2 | CRISPR Therapeutics AG | 5.03 Bn | 5.03 Bn | - |
| 3 | Iovance Biotherapeutics | 3.64 Bn | 3.35 Bn | 55.72 Mn |
| 4 | Legend Biotech | 3.54 Bn | 2.58 Bn | 251.50 Mn |
| 5 | uniQure | 2.98 Bn | 2.98 Bn | 5.49 Mn |
| 6 | Beam Therapeutics | 2.53 Bn | 2.53 Bn | - |
| 7 | Precigen | 2.40 Bn | 2.40 Bn | 52.17 Mn |
| 8 | Sarepta Therapeutics | 2.15 Bn | 1.36 Bn | 251.87 Mn |
| 9 | Vericel | 1.93 Bn | 1.77 Bn | 56.40 Mn |
| 10 | Humacyte | 133.67 Mn | 133.67 Mn | -825,000.00 |